Related Articles
bZIP transmembrane transcription factor CREBH: Potential role in non‑alcoholic fatty liver disease (Review)
Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review)
Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPKα in the liver
New insights into lipid metabolism and prostate cancer (Review)
Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease (Review)